Experienced in Anaphylaxis

Andreas Kerstan

Wuerzburg, BY, DE 
Experienced in Anaphylaxis
Wuerzburg, BY, DE 
OverviewLocationsClinical Research

Overview

Andreas Kerstan practices in Wuerzburg, Germany. Mr. Kerstan is rated as an Experienced expert by MediFind in the treatment of Anaphylaxis. His top areas of expertise are Varicose Veins, Acute Febrile Neutrophilic Dermatosis, Pityriasis Rubra Pilaris, and Cutaneous T-Cell Lymphoma (CTCL).

His clinical research consists of co-authoring 63 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Anaphylaxis.

Gender
Male

Locations

Wuerzburg, BY 97080, Germany
Other Locations
Strasse, NW 76337, Germany
Germany
Bochum, NW 44801, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Interventional, Single Arm, Multicenter, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-CVU on Wound Healing of Chronic Venous Ulcer (CVU)
An Interventional, Single Arm, Multicenter, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-CVU on Wound Healing of Chronic Venous Ulcer (CVU)
Enrollment Status: Completed
Publish Date: September 10, 2020
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
An Interventional, Single Arm, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of APZ2 on Wound Healing of Chronic Venous Ulcer (CVU)
An Interventional, Single Arm, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of APZ2 on Wound Healing of Chronic Venous Ulcer (CVU)
Enrollment Status: Terminated
Publish Date: July 07, 2020
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

63 Total Publications

NFATc1 Abrogation in B Cells Ameliorates Contact Hypersensitivity Responses.
NFATc1 Abrogation in B Cells Ameliorates Contact Hypersensitivity Responses.
Journal: International journal of molecular sciences
Published: July 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kerstan's expertise for a condition
ConditionClose
        View All 15 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile